Free Trial

CWA Asset Management Group LLC Buys New Stake in Colgate-Palmolive (NYSE:CL)

Colgate-Palmolive logo with Consumer Staples background

CWA Asset Management Group LLC acquired a new stake in Colgate-Palmolive (NYSE:CL - Free Report) in the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor acquired 25,786 shares of the company's stock, valued at approximately $2,677,000.

A number of other institutional investors have also bought and sold shares of the business. Price T Rowe Associates Inc. MD boosted its position in shares of Colgate-Palmolive by 27.8% during the 1st quarter. Price T Rowe Associates Inc. MD now owns 41,067,130 shares of the company's stock valued at $3,698,096,000 after acquiring an additional 8,933,912 shares during the last quarter. Massachusetts Financial Services Co. MA boosted its holdings in Colgate-Palmolive by 40.7% in the 2nd quarter. Massachusetts Financial Services Co. MA now owns 8,969,498 shares of the company's stock valued at $870,400,000 after purchasing an additional 2,593,313 shares during the last quarter. Legal & General Group Plc grew its stake in shares of Colgate-Palmolive by 0.8% in the 2nd quarter. Legal & General Group Plc now owns 7,785,101 shares of the company's stock valued at $755,465,000 after buying an additional 61,413 shares during the period. GUARDCAP ASSET MANAGEMENT Ltd increased its holdings in shares of Colgate-Palmolive by 4.1% during the 1st quarter. GUARDCAP ASSET MANAGEMENT Ltd now owns 6,987,454 shares of the company's stock worth $629,220,000 after buying an additional 278,150 shares during the last quarter. Finally, Acadian Asset Management LLC raised its position in shares of Colgate-Palmolive by 108.4% during the 2nd quarter. Acadian Asset Management LLC now owns 5,682,280 shares of the company's stock valued at $551,367,000 after buying an additional 2,955,442 shares during the period. 80.41% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

Several research firms have issued reports on CL. Hsbc Global Res cut Colgate-Palmolive from a "strong-buy" rating to a "hold" rating in a research note on Friday, July 26th. Barclays boosted their price objective on shares of Colgate-Palmolive from $91.00 to $96.00 and gave the company an "equal weight" rating in a report on Monday, July 29th. Redburn Atlantic raised shares of Colgate-Palmolive to a "hold" rating in a research report on Thursday, August 1st. Evercore ISI lifted their price target on shares of Colgate-Palmolive from $100.00 to $106.00 and gave the company an "outperform" rating in a research report on Thursday, July 18th. Finally, Jefferies Financial Group lowered shares of Colgate-Palmolive from a "buy" rating to a "hold" rating and decreased their price objective for the stock from $103.00 to $95.00 in a report on Wednesday, July 24th. One investment analyst has rated the stock with a sell rating, nine have assigned a hold rating and thirteen have assigned a buy rating to the company. According to MarketBeat.com, the stock presently has a consensus rating of "Moderate Buy" and an average price target of $105.11.

Read Our Latest Stock Analysis on Colgate-Palmolive

Insider Activity

In other Colgate-Palmolive news, Director Martina Hundmejean sold 2,313 shares of the firm's stock in a transaction that occurred on Friday, August 23rd. The shares were sold at an average price of $103.86, for a total transaction of $240,228.18. Following the sale, the director now owns 11,755 shares of the company's stock, valued at approximately $1,220,874.30. This trade represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. In related news, CFO Stanley J. Sutula III sold 45,410 shares of the company's stock in a transaction dated Tuesday, November 5th. The stock was sold at an average price of $94.11, for a total value of $4,273,535.10. Following the completion of the sale, the chief financial officer now directly owns 36,726 shares of the company's stock, valued at $3,456,283.86. This represents a 0.00 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, Director Martina Hundmejean sold 2,313 shares of Colgate-Palmolive stock in a transaction that occurred on Friday, August 23rd. The stock was sold at an average price of $103.86, for a total value of $240,228.18. Following the transaction, the director now directly owns 11,755 shares in the company, valued at approximately $1,220,874.30. This trade represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. Company insiders own 0.34% of the company's stock.

Colgate-Palmolive Stock Up 2.0 %

NYSE:CL traded up $1.80 during mid-day trading on Friday, hitting $92.57. The stock had a trading volume of 4,568,042 shares, compared to its average volume of 4,630,135. Colgate-Palmolive has a twelve month low of $74.67 and a twelve month high of $109.30. The stock has a 50-day simple moving average of $100.91 and a two-hundred day simple moving average of $98.44. The company has a current ratio of 1.04, a quick ratio of 0.68 and a debt-to-equity ratio of 9.46. The company has a market capitalization of $75.63 billion, a PE ratio of 26.52, a PEG ratio of 3.22 and a beta of 0.42.

Colgate-Palmolive Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, November 15th. Stockholders of record on Friday, October 18th will be given a dividend of $0.50 per share. The ex-dividend date is Friday, October 18th. This represents a $2.00 annualized dividend and a dividend yield of 2.16%. Colgate-Palmolive's dividend payout ratio is currently 57.31%.

Colgate-Palmolive Company Profile

(Free Report)

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.

Recommended Stories

Institutional Ownership by Quarter for Colgate-Palmolive (NYSE:CL)

Should you invest $1,000 in Colgate-Palmolive right now?

Before you consider Colgate-Palmolive, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Colgate-Palmolive wasn't on the list.

While Colgate-Palmolive currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

These 7 Stocks Will Be Magnificent in 2024 Cover

With average gains of 150% since the start of 2023, now is the time to give these stocks a look and pump up your 2024 portfolio.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

These Top Stocks in 2024 Will Continue to be Big Winners in 2025
’Best Report in 2 Years’: NVIDIA Earnings Crushes Expectations Again
Palantir and the NASDAQ 100: What’s the Next Big Stock Swing for This AI Giant?

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines